Humana Valuation
| HUM Stock | EUR 277.90 4.00 1.42% |
At this time, the firm appears to be overvalued. Humana Inc retains a regular Real Value of €227.39 per share. The prevalent price of the firm is €277.9. Our model calculates the value of Humana Inc from evaluating the firm fundamentals such as Current Valuation of 60.06 B, return on asset of 0.0611, and Return On Equity of 0.18 as well as inspecting its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Humana's price fluctuation is very steady at this time. Calculation of the real value of Humana Inc is based on 3 months time horizon. Increasing Humana's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Humana stock is determined by what a typical buyer is willing to pay for full or partial control of Humana Inc. Since Humana is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Humana Stock. However, Humana's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 277.9 | Real 227.39 | Hype 277.9 | Naive 283.88 |
The real value of Humana Stock, also known as its intrinsic value, is the underlying worth of Humana Inc Company, which is reflected in its stock price. It is based on Humana's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Humana's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Humana Inc helps investors to forecast how Humana stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Humana more accurately as focusing exclusively on Humana's fundamentals will not take into account other important factors: Humana Total Value Analysis
Humana Inc is currently estimated to have takeover price of 60.06 B with market capitalization of 57.99 B, debt of 9.03 B, and cash on hands of 13.75 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Humana fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
60.06 B | 57.99 B | 9.03 B | 13.75 B |
Humana Investor Information
About 96.0% of the company shares are owned by institutional investors. The book value of Humana was currently reported as 122.51. The company has Price/Earnings To Growth (PEG) ratio of 1.32. Humana Inc recorded earning per share (EPS) of 20.79. The entity last dividend was issued on the 30th of March 2023. Based on the key measurements obtained from Humana's financial statements, Humana Inc is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.Humana Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Humana has an asset utilization ratio of 215.7 percent. This implies that the Company is making €2.16 for each dollar of assets. An increasing asset utilization means that Humana Inc is more efficient with each dollar of assets it utilizes for everyday operations.Humana Ownership Allocation
Humana Inc has a total of 124.97 Million outstanding shares. The majority of Humana Inc outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in Humana to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in Humana Inc. Please pay attention to any change in the institutional holdings of Humana Inc as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.Humana Profitability Analysis
The company reported the revenue of 92.87 B. Net Income was 2.81 B with profit before overhead, payroll, taxes, and interest of 17.18 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Humana's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Humana and how it compares across the competition.
About Humana Valuation
The stock valuation mechanism determines Humana's current worth on a weekly basis. Our valuation model uses a comparative analysis of Humana. We calculate exposure to Humana's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Humana's related companies.Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky. HUMANA INC operates under Health Care Plans classification in Germany and is traded on Frankfurt Stock Exchange. It employs 41600 people.
8 Steps to conduct Humana's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Humana's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Humana's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Humana's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Humana's revenue streams: Identify Humana's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Humana's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Humana's growth potential: Evaluate Humana's management, business model, and growth potential.
- Determine Humana's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Humana's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for Humana Stock analysis
When running Humana's price analysis, check to measure Humana's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Humana is operating at the current time. Most of Humana's value examination focuses on studying past and present price action to predict the probability of Humana's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Humana's price. Additionally, you may evaluate how the addition of Humana to your portfolios can decrease your overall portfolio volatility.
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |